PAVmed Inc. (PAVM) Tops Q3 EPS by 5c

PAVmed Inc. (NASDAQ: PAVM) reported Q3 EPS of ($0.09), $0.05 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $790 thousand versus the consensus estimate of $658 thousand.

For earnings history and earnings-related data on PAVmed Inc. (PAVM) click here.

You May Also Be Interested In

• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
• Occidental Petroleum releases Q2 2026 earnings considerations
• Delta Air Lines stock climbs on earnings beat and strong guidance